Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript - Thomson StreetEvents

Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript

Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript - Thomson StreetEvents
Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript
Published Aug 03, 2022
Published Aug 03, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ALNY.OQ conference call or presentation 3-Aug-22 12:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Alnylam Pharmaceuticals Inc
Ticker
ALNY.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Results at HFSA Scientific Meeting Transcript – 2022-10-01 – US$ 54.00 – Edited Transcript of ALNY.OQ corporate analyst meeting</ 1-Oct-22 12:00am GMT

Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript – 2022-09-13 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 13-Sep-22 3:10pm GMT

Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Results - Conference Call Transcript – 2022-09-08 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 8-Sep-22 12:00pm GMT

Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Summary – 2022-08-03 – US$ 54.00 – Edited Brief of ALNY.OQ conference call or presentation 3-Aug-22 12:00pm GMT

Alnylam Pharmaceuticals Inc Q2 2022 Earnings Call Summary – 2022-07-28 – US$ 54.00 – Edited Brief of ALNY.OQ earnings conference call or presentation 28-Jul-22 12:30pm GMT

Alnylam Pharmaceuticals Inc Q2 2022 Earnings Call Transcript – 2022-07-28 – US$ 54.00 – Edited Transcript of ALNY.OQ earnings conference call or presentation 28-Jul-22 12:30pm GMT

Alnylam Pharmaceuticals Inc to Discuss FDA Approval of AMVUTTRA (Vutrisiran) Summary – 2022-06-14 – US$ 54.00 – Edited Brief of ALNY.OQ conference call or presentation 14-Jun-22 12:00pm GMT

Alnylam Pharmaceuticals Inc to Discuss FDA Approval of AMVUTTRA (Vutrisiran) Transcript – 2022-06-14 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 14-Jun-22 12:00pm GMT

Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript – 2022-06-13 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 13-Jun-22 9:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript" Aug 03, 2022. Alacra Store. May 05, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Alnylam-Pharmaceuticals-Inc-to-Discuss-APOLLO-B-Topline-Results-T15285802>
  
APA:
Thomson StreetEvents. (2022). Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript Aug 03, 2022. New York, NY: Alacra Store. Retrieved May 05, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Alnylam-Pharmaceuticals-Inc-to-Discuss-APOLLO-B-Topline-Results-T15285802>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.